KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Tax Provisions (2020 - 2025)

Ginkgo Bioworks Holdings' Tax Provisions history spans 6 years, with the latest figure at -$643000.0 for Q4 2025.

  • For Q4 2025, Tax Provisions fell 97.85% year-over-year to -$643000.0; the TTM value through Dec 2025 reached -$837000.0, down 74.74%, while the annual FY2025 figure was -$837000.0, 74.74% down from the prior year.
  • Tax Provisions reached -$643000.0 in Q4 2025 per DNA's latest filing, down from $1000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $190000.0 in Q2 2024 to a low of -$14.8 million in Q4 2022.
  • Average Tax Provisions over 5 years is -$894700.0, with a median of -$171500.0 recorded in 2021.
  • Peak YoY movement for Tax Provisions: crashed 3550.0% in 2021, then skyrocketed 248.89% in 2023.
  • A 5-year view of Tax Provisions shows it stood at -$683000.0 in 2021, then tumbled by 2062.52% to -$14.8 million in 2022, then skyrocketed by 98.66% to -$198000.0 in 2023, then crashed by 64.14% to -$325000.0 in 2024, then plummeted by 97.85% to -$643000.0 in 2025.
  • Per Business Quant, the three most recent readings for DNA's Tax Provisions are -$643000.0 (Q4 2025), $1000.0 (Q3 2025), and -$283000.0 (Q2 2025).